Navigation Links
NUCRYST Appoints David B. Holtz as Vice President and Chief Financial Officer
Date:5/7/2008

l leadership."

About NUCRYST Pharmaceuticals

NUCRYST Pharmaceuticals (NASDAQ: NCST; TSX: NCS) develops, manufactures and commercializes medical products that fight infection and inflammation using its patented atomically disordered nanocrystalline silver technology. Smith & Nephew plc sell a range of advanced wound care products under their Acticoat(TM) trade mark. Acticoat(TM) products incorporate NUCRYST's SILCRYST(TM) coatings and are sold in over 30 countries. NUCRYST is also developing pharmaceutical products to address medical conditions that are characterized by both infection and inflammation. The Company has developed its proprietary nanocrystalline silver in a powder form, referred to as NPI 32101 for use in medical devices and as an active pharmaceutical ingredient.

Acticoat(TM) is a trademark of Smith & Nephew plc

SILCRYST(TM) is a trademark of NUCRYST Pharmaceuticals Corp.

This news release contains forward-looking statements within the meaning of securities legislation in the United States and Canada (collectively "forward-looking statements"). The words "believes", "expects", "plans", "anticipates", "estimates", "intends", "projects", "may", "might", "would", "will", "could", "should" and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. Forward-looking statements in this news release include, but are not limited to, statements about: our strategy, future operations, prospects and plans of management and our ability to successfully expand the company's business and achieve operating efficiencies and cost reductions. With respect to the forward-looking statements contained in this news release, read
'/>"/>

SOURCE NUCRYST Pharmaceuticals Corp.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. NUCRYST and Smith & Nephew Revise Agreements
2. Webcast Advisory - NUCRYST Pharmaceuticals Webcast of Conference Call to Discuss 2007 Third Quarter Results
3. NUCRYST Pharmaceuticals announces 2007 third quarter results
4. NUCRYST Pharmaceuticals announces year-end results
5. NUCRYST Announces Senior Management Change
6. NUCRYST Announces Management Realignment and R&D Portfolio Change
7. NUCRYST Announces First Quarter 2008 Financial Results
8. WorldHeart Appoints David Pellone Chief Financial Officer
9. Novo Nordisk Appoints New Leader of North American Business
10. Millstone Medical Outsourcing Appoints Operations Manager of New Memphis, TN, Facility
11. China Holdings Appoints Ronald Shon Chairman of Advisory Board to Its Wholly-Owned Subsidiary China Power, Inc.

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)...,, AmericanCollegeofMedicalGenetics(ACMG)Enc...iononNationalFamilyHistoryDay,Thanksgiving2009 ,...isThanksgivingisthesixthannualNationalFamilyHistor...CollegeofMedicalGenetics(ACMG)encourageseveryoneto...dygatheredthispotentiallylife-savinginformation,to...
(Date:11/23/2009)...More open on-the-job interaction might ease the pr...23 (HealthDay News) -- Men who bottle up their ang...their hearts, a new Swedish study indicates. , ...tment over conflicts with a fellow worker or super...rt attack or die of heart disease as those who ven...
(Date:11/23/2009)...,, ActingSecretaryEncouragesUseofPAPreferredP...PRNewswire-USNewswire/--Toensurethatyourfamilyhasa...etaryRussellReddingisurgingresidentstofollowafewba...ftovers. ,, "Followingandunderstandingproperfoo...makingsureyourThanksgivingdinnerissafetoeat,"saidR...
(Date:11/23/2009)...,, HATBORO,Pa.,Nov.23/PRNewswire-FirstCall/--...oviderofenterprisemobilitysolutionsforthehealthcar...formerVicePresidentofManagedServicesatSiemensHealt...egicHealthcareServices. ,, (Logo: http://www.ne..., AsVicePresidentofStrategicHealthcareServicesforI...
(Date:11/23/2009)...,, ClinicsContinuetoTargetIndividualsintheRec... /PRNewswire-USNewswire/--TheDepartmentofHealthan...inationclinicsatlocalStateHealthCentersinDelaware,...nesday,Nov.25.TheH1N1vaccinewillbeadministeredforf...venothadpreviousaccesstothevaccine.Thedepartmentas...
Breaking Medicine News(10 mins):Health News:'Family Health History and Genetics Privacy' is the Newest Addition to the ACMG Genetics & Your Health Video Series 2Health News:Stifled Anger at Work Doubles Men's Risk for Heart Attack 2Health News:Stifled Anger at Work Doubles Men's Risk for Heart Attack 3Health News:Pennsylvania Agriculture Department Encourages Proper Food Handling, Offers Safety Tips for Thanksgiving 2Health News:Jim Way, Former Vice President at Siemens Health Services, Joins InfoLogix, Inc. as Vice President of Strategic Healthcare Services 2Health News:Jim Way, Former Vice President at Siemens Health Services, Joins InfoLogix, Inc. as Vice President of Strategic Healthcare Services 3Health News:Pennsylvania Department of Health Announces Additional H1N1 Vaccination Clinics in Delaware, Lancaster, Lehigh Counties 2
...discovery reveals a new cause of thyroid cancer. R...tumors, one of three genetic changes // happen. T...atients have not been exposed to radiation, the ch...e gene changes or mutations transform normal cells...
...ing to the Centers for Disease Control and Prevent...living with HIV.// Human Immuno Deficiency Virus ... Previous research has shown circumcised men ar...ey found each sample contained cells expressing th...
...nk between migraines and the risk of coronary hear...t study shows // no link between the two but does ...est pain, also known as angina. People with a h...port a history of chest pain than those without a ...
...chers now say they’ve found one drug that may succ...cancer.// For the study 22 patients with breast, p...r were involved , 42 percent had their tumors eith... so there’s much less side effects because it targ...
...study finds Alzheimer’s patients lose the ability ...sease progresses. // Researchers conducted a st... skills and Alzheimer’s disease. The study include... The study also included 23 healthy elderly people...
...chers say their discovery of a new compound known ...conjunction with // chemotherapy drugs such as cis...over 48 hours, small amounts of SP-4-84 made campt... caused by chemotherapeutic drugs. However, this w...
Other Medicine News:
(Date:11/23/2009)...Nov.23/PRNewswire-USNewswire/--FebeDurango-Rueda,5...participatinginaschemetodefraudtheExport-ImportBan...nnouncedAssistantAttorneyGeneraloftheCriminalDivis...GratacosoftheEx-ImBank,OfficeoftheInspectorGeneral...bertsinU.S.DistrictCourtinWashingtontoaone-countcr...
(Date:11/23/2009)....23/PRNewswire/--TwooftheChicagoarea,sleadingBoard...rainwomen,sbreastimaging,couplingthelatesttechnolo...rasoundwiththeabilitytohavethefullrangeofdigitalim...beforesheleavestheoffice.Drs.AhmedFaragandJoanWerb...tthecurrent6-9monthwaitforanappointmentcommonlyfou...
(Date:11/23/2009)...alif.,Nov.23/PRNewswire-FirstCall/--AccurayIncorpo...osurgery,announcedtodaythatitsmanagementisschedule...ferenceinNewYorkonTuesday,December1,2009at9:00a.m....rganSmall/MidCapConferenceinNewYorkonThursday,Dece...castofeachpresentationwillbeavailableonlinefromthe...
Breaking Medicine Technology:Colombian National Pleads Guilty to Role in Defrauding the Export-Import Bank of the United States of More Than $1 Million 2Accuray Incorporated to Present at Piper Jaffray Healthcare Conference and J. P. Morgan Small/Mid Cap Conference 2Acupuncture may bring relief for a common condition in women 54970 1Acupuncture may bring relief for a common condition in women 54970 2Switching on the power of stem cells 9639 1Switching on the power of stem cells 9639 2Princeton team learns why some drugs pack such a punch 9635 1Princeton team learns why some drugs pack such a punch 9635 2Princeton team learns why some drugs pack such a punch 9635 3
....m. today, Thursday, August 16, 2007, MALVERN, Pa...: AUXL ) today announced that the Company has,rec...stration ("FDA") to,resume its phase III clinical ...jection), formerly referred to as AA4500, in the t...ill hold a conference call today,August 16, at 10:...
...on on Track -, BRISBANE, Australia, Aug. 16 Prog...) today announced it has,executed an agreement wit...,Organisation, to utilise their services for a num...s agreement includes the execution of the,Phase 3 ...reatment of,primary liver cancer (hepatocellular c...
Other Medicine Technology:Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM) 2Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM) 3Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM) 4Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM) 5Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM) 6Progen Engages Leading CRO to Assist with Phase 3 Trial of PI-88 2Progen Engages Leading CRO to Assist with Phase 3 Trial of PI-88 3
Buffered Wright-Giemsa Stain
Giemsa Stain
Albumin (BCP)
Albumin Reagent Set
Medicine Products: